KalVista Pharmaceuticals, Inc. (KALV)
16.85
+0.69
(+4.27%)
USD |
NASDAQ |
Dec 10, 16:00
16.85
0.00 (0.00%)
After-Hours: 19:13
KalVista Pharmaceuticals Total Assets (Quarterly): 339.93M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 446.42M |
| Revolution Medicines, Inc. | 2.252B |
| Silvergate Capital Corp. | -- |
| Perspective Therapeutics, Inc. | 294.82M |
| Electromed, Inc. | 53.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 322.93M |
| Shareholders Equity (Quarterly) | 17.00M |
| Debt to Equity Ratio | 16.62 |
| Current Ratio | 7.216 |
| Net Debt Paydown Yield | -8.98% |